Variational AI Files Two US Provisional Patents for Potential COVID-19 Drug Created by Generative AI
Read more: Variational AI Files Two US Provisional Patents for Potential COVID-19 Drug Created by Generative AIVariational AI, developer of the Enki™ generative artificial intelligence (AI) drug discovery platform to redefine the economics of drug development, today announced that the company has filed two provisional patents… Read More about Variational AI Files Two US Provisional Patents for Potential COVID-19 Drug Created by Generative AI
Variational AI Adds Jennifer Hamilton as Advisor
Read more: Variational AI Adds Jennifer Hamilton as AdvisorVariational AI, developer of generative AI-based drug discovery platform for novel kinase inhibitors, today announced that it has added industry and scientific leader Jennifer Hamilton, Ph.D. as a company advisor. Read More about Variational AI Adds Jennifer Hamilton as Advisor
Variational AI Adds Leading Oncology Researchers to Scientific Advisory Board
Read more: Variational AI Adds Leading Oncology Researchers to Scientific Advisory BoardVariational AI, developer of generative AI-based drug discovery platform for novel kinase inhibitors, today announced that it has added industry and scientific leaders Dr. John F. Boylan and Dr. Mads… Read More about Variational AI Adds Leading Oncology Researchers to Scientific Advisory Board